Stonkey
Posted - 22 minutes from now
$APLT Racing to zero with the speed of light....
543688Ireland
Posted - 42 minutes ago
$APLT Strategic Partnership news would be awesome! The company has been kinda quiet with top officials stepping down. This is Just speculation but it seems as if something is cooking. 🧑🍳
543688Ireland
Posted - 2 hours ago
$APLT I’m not hating on the shorts here, the lower I can add the better. The sell off is ridiculous at this point, but I’m not complaining.
RealInfo
Posted - 4 hours ago
$APLT Hey , where are all of the EXPERTS who were saying in October and early November "Don't let THEM steal your shares...We're in this til the end!" I assume you are all buried in a hole somewhere cuz we don't hear you yapping anymore. Unless you're the idiots that keep saying BUY THE DIP everytime this POS goes down another 10 cents.
RockBottomChartz
Posted - 4 hours ago
$APLT ehhhh good morning.
investmenteagle
Posted - 22 hours ago
$APLT sell and take the tax loss write off. being Shendelman'ed is not cool. She'll be enjoying her Hanukah, while some of us will be in pain this Christmas.
investmenteagle
Posted - 22 hours ago
$APLT nobody found it sus that Shoshana Shendelman sold a chunk of her lot before the CRL?
RockBottomChartz
Posted - 23 hours ago
$APLT Merry Christmas from the Rock
Article_AI
Posted - 1 day ago
$APLT Analysts Are Bullish on Top Healthcare Stocks: Oruka Therapeutics (ORKA), Vertex Pharmaceuticals (VRTX) There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oruka Therapeutics (ORKA – Research Report), Vertex ... https://www.stck.pro/news/APLT/96895044/
RealInfo
Posted - 1 day ago
$APLT So none of you BULLS are concerned with the 18 law firms soliciting investors to join in a Class Action Lawsuit against Soshanna and her band of idiots? Yes, I realize she has left the building but her stench remains with the company forever. I know your reply is "BUY THE DIP"... The Day Trader's are playing the long term investors for the Fool's they are.
Germany2020
Posted - 1 day ago
$APLT what else in their pipeline guys? Wanna b&h for a year / two..
alancg
Posted - 1 day ago
$APLT It’s always the same; the time to buy is when everyone else is selling.
DJW009
Posted - 1 day ago
$APLT 87% institutional holdings say you are wrong
DJW009
Posted - 1 day ago
$APLT Let's hold out for $4.
543688Ireland
Posted - 1 day ago
$APLT Taking a flyer here as I believe something positive will come of this soon. Not investment advice, I just have that feeling.
Billions2020
Posted - 1 day ago
$APLT gimme $2.00 i will be gone!
Hayaninvestr85
Posted - 1 day ago
$APLT MAGA (make ALPT great again)
CAMDENBEER
Posted - 1 day ago
$APLT tax loss harvesting will be here for the next few years. MANY people need to use losses to offset their winners in 2024. also, smart money needs to get the trash out of their portfolios before year end. you can't tell your investors you own trash like APLT
JackLarson369
Posted - 1 day ago
$APLT Working to bottom here. Reversal risk/reward looks good.
GoldmanSlaps
Posted - 1 day ago
$APLT what is this greeen color?!?
showmethemoney75
Posted - 1 day ago
$APLT We got rid of the devil let’s go!!!!
showmethemoney75
Posted - 1 day ago
$APLT Jesus is now super bullish on this stock 20K shares long. Will go green. Looking for 1.25 by first week of new year!!!
RockBottomChartz
Posted - 1 day ago
$APLT volume increase.
RockBottomChartz
Posted - 1 day ago
$APLT fake sales. Nobody sells at the ATL.
Stonkey
Posted - 1 day ago
$APLT Bleeding to death with the speed of light....
RockBottomChartz
Posted - 2 days ago
$APLT new ceo. New path forward.
BioIngenieur
Posted - 2 days ago
$APLT Applied Therapeutics (APLT) offers an exciting investment opportunity with govorestat and a strong pipeline. Its orphan drug status provides benefits like seven years of market exclusivity, additional FDA support, and tax incentives, reducing regulatory risks and strengthening its market position.
An FDA Complete Response Letter (CRL) is not uncommon and often surmountable. Examples like Tresiba and Brilinta demonstrate that approvals can follow after addressing concerns. Applied Therapeutics has strong potential to overcome similar challenges.
Beyond classical galactosemia, govorestat is being developed for SORD deficiency (Phase 3) and PMM2-CDG (Phase 2). Additional assets like AT-001 and AT-003 diversify APLT’s portfolio, mitigating risks.
With a market valuation of $100 million, APLT appears undervalued. Investors like Janus Henderson show confidence, and despite inherent risks, the company’s opportunities far outweigh the challenges.
ys95
Posted - 2 days ago
$APLT .86 and yet we have buyers. Slowly returning shares too but still have a ways to go. Jmo
mikeyd
Posted - 2 days ago
$APLT who’s the co—-k gobbler that has to try and sell AH at .84, jackoff